Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06258629
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-14
First Post:
2024-02-06
Brief Title:
Prognostic Value of CD200 in Hematological Malignancies Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues Including Leukemia Multiple Myeloma and They Have a High Morbidity and Mortality
Sponsor:
Sohag University
Organization:
Sohag University
Study Overview
Official Title:
Resident of Clinical Pathology in Sohag Oncology Center
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prognostic value of CD200 in hematological malignancies Hematological malignancies comprise a group of malignant clonal disorders arising from the hematopoietic tissues including leukemia multiple myeloma and lymphoma and they have a high morbidity and mortality
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None